| Style | Citing Format |
|---|---|
| MLA | Eslamian L, Ahmadi M, Ahmadi M. "Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During Covid-19: Should or Shouldn’T?." Iranian Journal of Pharmaceutical Research, vol. 20, no. 1, 2021, pp. 1-2. |
| APA | Eslamian L, Ahmadi M, Ahmadi M (2021). Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During Covid-19: Should or Shouldn’T?. Iranian Journal of Pharmaceutical Research, 20(1), 1-2. |
| Chicago | Eslamian L, Ahmadi M, Ahmadi M. "Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During Covid-19: Should or Shouldn’T?." Iranian Journal of Pharmaceutical Research 20, no. 1 (2021): 1-2. |
| Harvard | Eslamian L, Ahmadi M, Ahmadi M (2021) 'Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During Covid-19: Should or Shouldn’T?', Iranian Journal of Pharmaceutical Research, 20(1), pp. 1-2. |
| Vancouver | Eslamian L, Ahmadi M, Ahmadi M. Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During Covid-19: Should or Shouldn’T?. Iranian Journal of Pharmaceutical Research. 2021;20(1):1-2. |
| BibTex | @article{ author = {Eslamian L and Ahmadi M and Ahmadi M}, title = {Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During Covid-19: Should or Shouldn’T?}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {20}, number = {1}, pages = {1-2}, year = {2021} } |
| RIS | TY - JOUR AU - Eslamian L AU - Ahmadi M AU - Ahmadi M TI - Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During Covid-19: Should or Shouldn’T? JO - Iranian Journal of Pharmaceutical Research VL - 20 IS - 1 SP - 1 EP - 2 PY - 2021 ER - |